Position in RVTY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$332,667
+$53,834 QoQ
Shares Held
2,990
+3.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#319
of 538 holders
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVTY Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $8,065,103 across 7 Diagnostics & Research names. RVTY ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,919 | $2,967,549 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
4,970 | $2,616,406 | |
| 3 | DHR |
Danaher Corp /De/
|
5,562 | $1,059,449 | |
| 4 | LH |
Labcorp Holdings Inc.
|
1,551 | $434,280 | |
| 5 | RVTY |
Revvity, Inc.
This page
|
2,990 | $332,667 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,550 | $328,522 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,456 | $326,230 |
All Filings in RVTY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $332,667 | 2,990 | Shares | Sole | 2026-07-21 | |
| 2025-12-31 | $278,833 | 2,882 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $247,786 | 2,827 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $254,567 | 2,632 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $279,523 | 2,642 | Shares | Sole | 2025-05-05 | |
| 2020-09-30 | $475,306 | 3,787 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||